Marc Güell
Marc Güell
Datos de interés
Director Cofounder and Scientific Head Integra Therapeutics.
His laboratory is focused in leveraging new gene editing technologies for therapeutic purposes. Their two main lines of research are mammalian genome engineering and skin microbiome engineering. They recently launched Integra Therapeutics to combine the power of CRISPR technologies and transposasses for efficient gene writing of mammalian genomes. He received the National Research Prize to the Young talent (2018), named highly cited researcher (2019), elected EMBO Young Investigator (2020) and received the August Pi i Sunyer award (2021).
¿Qué necesitas?
Estamos aquí para ayudarte
¿Tienes alguna duda?
Contáctanos e intentaremos resolverla lo antes posible.
¿Quieres estar siempre al día?
Suscríbete a nuestra newsletter y no te pierdas ninguna novedad
¿Tienes alguna duda?